Trial Profile
Phase II Randomized Study to Compare Capecitabine + Bevacizumab Concomitantly With Radiotherapy Versus Capecitabine Concomitantly With Radiotherapy, as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Carcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms AVAROX; AVAXEL
- 12 Sep 2017 Final results of 3 and 5 year disease free survival,distant relapse free survival and overall survival, presented at the 42nd European Society for Medical Oncology Congress.
- 18 Oct 2016 Status changed from active, no longer recruiting to completed.
- 17 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.